vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors 3M Healthcare C. R. Bard Smiths Medical Stryker ZOLL Medical Other Prominent Vendors Augustine Temperature Management Belmont Instrument Charter Kontron Cincinnati Sub
markets. Nonetheless, we think how the regulators handle the Zimmer-Biomet situation may be instructive for any peer that might be taking a close look at Smith & Nephew as a target (we still think Stryker is the most likely taker).
Stryker reported fourth-quarter results that were ..... stronger growth from the European region as Stryker reorganizes its structure there, and peripherally ..... realized since our last update. We still think Stryker enjoys a wide economic moat, bolstered
Jan 27 (Reuters) - The chief executive officer of U.S. medical device maker Stryker Corp , recently rumored to have been preparing a bid for British rival Smith & Nephew Plc , said on Tuesday that...
CHICAGO, Jan 27 (Reuters) - Stryker Corp : * CEO says first priority for company's cash is acquisitions * CEO: "Right now we are pursuing the acquisition deal flow" * CEO: "Obviously the timing of...
fell 250 basis points, which stands in contrast with the 500 basis points J&J saw and the 300-500 basis point erosion Stryker experienced. Management comments indicated hospital contracts have eased up on price, and pointed to extensive registry
Stryker reported strong third-quarter results ..... before deductibles are reset in January. Stryker 's ability to gain volume more than offsets ..... marketing expense. We were impressed by Stryker 's reconstruction business, which posted
Wide 78.56 1.08 67,980 2 Stryker SYK 3 Medium Wide 83.31 1.05 31,784 2 Data ..... about his sale of wide-moat rated Stryker SYK , which was completely out of the ..... stakes in Abbott Laboratories, Stryker , and Nike. We cut Abbott on inflated
standing midtier orthopedic companies, Smith & Nephew presents an attractive target to both Stryker and Johnson & Johnson, from our perspective. Though Stryker was forced to declare it would not pursue Smith & Nephew for six months, we would not
growth of 1% in constant currency, Zimmer trailed rivals Stryker and Johnson & Johnson's DePuy business. In recent quarters ..... Zimmer's geographical contributions were a mirror image of Stryker 's—with much stronger international growth compensating